Study Led by TGen and City of Hope Shows New Way of Identifying Tumor Response to Immunotherapy
June 23, 2020
June 23, 2020
PHOENIX, Arizona, June 23 -- The Translational Genomics Research Institute issued the following news release on June 22:
Scientists at Translational Genomics Research Institute (TGen), working in collaboration with researchers at City of Hope and other colleagues across the country, have found that the actions of circulating immune cells -- namely how they differentiate and signal -- at the start of immunotherapy treatment for cancer can inform how a patient will respond to the ther . . .
Scientists at Translational Genomics Research Institute (TGen), working in collaboration with researchers at City of Hope and other colleagues across the country, have found that the actions of circulating immune cells -- namely how they differentiate and signal -- at the start of immunotherapy treatment for cancer can inform how a patient will respond to the ther . . .